Autoimmune Life Blog

The National Institutes of Health recently awarded BRI an $8 million grant to lead the center—a collaboration of researchers from BRI, UW Medicine and Seattle Children’s Research Institute.

Benaroya Research Institute at Virginia Mason (BRI) is waging a comprehensive fight against rheumatoid arthritis (RA). “During the last 15 years, treatments for RA have improved enormously with new therapies,” says BRI President Jane Buckner, MD, who is leading this work.

"If it wasn’t for the Murdock Trust helping us with essential pieces of equipment and new technology for over 30 years, we wouldn’t have been able to achieve our cutting-edge research advancements,” says BRI President Jane Buckner, MD.

One in four people in the United States grapple with allergies, asthma or both. For years, BRI has had its sights set on helping these patients breathe easier. And our efforts just got a huge and welcome boost.

Benaroya Research Institute (BRI) and Seattle Children’s Research Institute (SCRI) are pioneering the use of gene editing techniques in efforts to control type 1 diabetes (T1D).

This research update is on a variety of studies that BRI is conducting or collaborating on with other institutions. They are tackling various scientific and immunologic questions that explore innovative ways to fight MS from the lab to clinical studies.

Benaroya Research Institute at Virginia Mason (BRI) is relatively small compared to large research universities, but its impact goes well beyond its size and location, accelerating scientific discovery globally.

In the early 1980s, the leadership team at Virginia Mason made the important decision to establish a biomedical research center focused on immunology. Immunology at that time was an emerging field, anticipating a future era of medical applications.

Researchers at BRI have used cutting-edge tetramer technology developed at BRI to find the T cells that drive rheumatoid arthritis (RA).

Multiple sclerosis (MS) affects more than a million people worldwide including 15,000 in the Northwest. It affects women twice as often as men. MS is the most common medical cause of neurological disability in young adults ages 20-40. Usually MS happens in multiple attacks.